Figure 3
From: MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis

Comparing the expression of miR-27a between different binary situations. (a) comparison of miR-27a expression patients positive or negative for DNA topoisomerase (SCL70), (b) Comparison of miR-27a expression patients positive or negative for anti-centromere antibody, (c) comparison of miR-27a expression patients positive or negative for ribonucleoprotein autoantibody, (d) comparison of miR-27a expression patients positive or negative for interstitial lung disease, (e) comparison of miR-27a expression patients positive or negative for pulmonary arterial hypertension, (f) comparison of miR-27a expression patients positive or negative for myositis, (g) comparison of miR-27a expression patients positive or negative for digital ulcers, (h) comparison of miR-27a expression patients positive or negative for telangiectasia, and, comparison of miR-27a expression between female and the few male cases.